Homology Medicines Inc (FIXX): CFO is from PFE and Shire and the rest o...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Homology Medicines Inc (FIXX)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	1062
Posts	141580
Boards Moderated	14
Alias Born	03/31/2006

Re: Rockurstocks post# 23

Friday, 01/15/2021 3:11:18 PM

Friday, January 15, 2021 3:11:18 PM

CFO is from PFE and Shire and the rest of management is all from Shire...

Shire
Biotechnology company

Shire plc was a Jersey-registered specialty biopharmaceutical company. Originating in the United Kingdom with an operational base in the United States, its brands and products included Vyvanse, Lialda, and Adderall XR. Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019. Wikipedia
Headquarters: Lexington, MA
CEO: Flemming Ørnskov (Apr 30, 2013–)
Revenue: 15.16 billion USD
Number of employees: 23,044 (2018)
Parent organization: Takeda Pharmaceutical Company

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent FIXX News

Homology Medicines Declares Distribution to Common Stockholders • GlobeNewswire Inc. • 03/18/2024 08:30:00 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/11/2024 11:37:28 AM
Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 11:32:56 AM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/21/2024 09:04:56 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/15/2024 05:15:36 AM
Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 02/13/2024 03:11:43 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 10:54:35 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 10:49:06 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 01/03/2024 09:29:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 09:26:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:15:24 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:15:15 PM
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency • GlobeNewswire Inc. • 01/03/2024 09:08:55 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:05:19 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 09:19:25 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 09:16:27 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 09:13:55 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 12:46:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 12:45:00 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 12:17:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 12:16:09 PM
Q32 Bio and Homology Medicines Announce Merger Agreement • GlobeNewswire Inc. • 11/16/2023 12:05:00 PM
Q32 Bio and Homology Medicines Announce Merger Agreement • PR Newswire (US) • 11/16/2023 12:05:00 PM
Homology Medicines Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/14/2023 09:33:57 PM

More FIXX News

InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow